Stryker Corporation (SYK) is listed on NYSE in Medical Device Stocks. It is $330.77, +2.69%, with a $126.9B market cap. RSI is 51.3, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 51.3 Neutral
Market Cap $126.9B
P/E Ratio 63.2x
Volume 1.5M
Fundamentals — 10-Q Q2 2026
Revenue $12.6B
Net Income $2.0B
EPS $5.23
Gross Margin 65.9%
Operating Margin 20.6%
Net Margin 16.0%
Debt / Equity 0.6x
P/E Ratio 63.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Crotty Dylan Bram | Group President | Sell | 441 | $328.61 | $144,915 | 2026 Aug 21 |
| Stryker Ronda E | Director | Sell | 350,000 | $336.50 | $117.8M | 2026 Aug 19 |
| King Debra | Officer | Sell | 826 | $336.30 | $277,787 | 2026 Aug 18 |
| Fletcher Robert S | VP, Chief Legal Officer | Sell | 4,544 | $306.87 | $1.4M | 2026 May 28 |
| Stryker Ronda E | Director | Sell | 310,000 | $312.23 | $96.8M | 2026 May 26 |
| Fink M Kathryn | VP, Chief HR Officer | Sell | 8,720 | $283.69 | $2.5M | 2026 May 11 |
| Wells Preston Wendell | VP, Chief Financial Officer | Sell | 165 | $365.88 | $60,370 | 2025 Nov 20 |
| Berry William E Jr | VP, Chief Accounting Officer | Sell | 1,953 | $365.49 | $713,802 | 2025 Nov 14 |
| Stryker Ronda E | Director | Sell | 520,000 | $355.01 | $184.6M | 2025 Nov 6 |
| Menon Viju | Group President | Sell | 500 | $390.61 | $195,305 | 2025 Aug 25 |
| Fletcher Robert S | VP, Chief Legal Officer | Sell | 1,785 | $393.07 | $701,630 | 2025 Aug 20 |
| Stryker Ronda E | Director | Sell | 200,000 | $376.45 | $75.3M | 2025 Aug 6 |
| Berry William E Jr | VP, Chief Accounting Officer | Sell | 1,241 | $388.56 | $482,203 | 2025 May 12 |
| Stryker Ronda E | Director | Sell | 200,000 | $376.96 | $75.4M | 2025 May 6 |
| Golston Allan C. | Director | Sell | 2,458 | $383.07 | $941,586 | 2025 Feb 18 |
| Stryker Ronda E | Director | Sell | 201,392 | $392.24 | $79.0M | 2025 Jan 31 |
| Stiles Spencer S | Group President | Sell | 514 | $391.16 | $201,056 | 2024 Nov 15 |
| Lobo Kevin | Chair and CEO | Sell | 57,313 | $368.70 | $21.1M | 2024 Nov 7 |
| Stryker Ronda E | Director | Sell | 230,000 | $367.37 | $84.5M | 2024 Nov 5 |
| Fink M Kathryn | VP, Chief HR Officer | Sell | 9,468 | $367.66 | $3.5M | 2024 Sep 17 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $91.21 | 57.7 | $116.7B |
| | $372.55 | 49.7 | $131.6B |
| | $174.34 | 51.8 | $89.9B |
| | $240.31 | 72.0 | $34.7B |
| | $35.28 | 47.1 | $29.6B |
| | $90.19 | 55.1 | $52.0B |
| | $90.82 | 63.9 | $34.3B |
Take SYK further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put SYK in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Stryker Corporation next reports.
Set alerts on SYK
Get notified when Stryker Corporation hits your price targets or technical conditions are met.
Get Started Free